Vertex Pharmaceuticals Incorporated (VRTX) Stock | Share Price
VRTX · Health Care ·
United States
Vertex Pharmaceuticals Incorporated (VRTX) is a company in the Health Care sector, based in United States. The stock is held in 24 ETFs we track – with its largest weight of 2.18 % in XUHC (msci-usa-health-care). That means you can hold Vertex Pharmaceuticals Incorporated indirectly and diversified through an ETF savings plan.
Very high ETF coverage: 24 of the 95 ETFs we cover hold Vertex Pharmaceuticals Incorporated, spread across 12 indices. That puts the stock in more ETFs than 92.6 % of the 4,362 stocks we cover.
Price chart
Performance
| Year to date | +21.0 % | 1 year | +41.4 % |
|---|---|---|---|
| 1 month | +14.3 % | 3 months | +25.2 % |
| Calendar year 2025 | +12.6 % | ||
| Calendar year 2026 | +20.7 % |
Risk metrics
Correlated with
The strongest co-movers on top, the most inverse below. Low or negative values improve portfolio diversification.
| Instrument | r | −1 … +1 |
|---|---|---|
| Amgen Inc. | +0.60 | |
| AbbVie Inc. | +0.55 | |
| Royalty Pharma plc Class A | +0.54 | |
| Eli Lilly and Company | +0.53 | |
| Gilead Sciences Inc. | +0.49 | |
| Incyte Corporation | +0.46 | |
| Seagate Technology Holdings plc | -0.33 | |
| Hewlett Packard Enterprise Co. | -0.29 | |
| USD/CHF | -0.28 |
Key financials
Latest reported fiscal year (FY2025, period end 2025-12-31) as filed with the SEC.
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| FY2023 | 9.9 | 3.6 | 36.7 % |
| FY2024 | 11.0 | -0.5 | -4.9 % |
| FY2025 | 12.0 | 4.0 | 32.9 % |
Figures in USD bn. Source: SEC EDGAR (XBRL annual filings, public domain). US-listed SEC filers only.
Held in these ETFs
| ETF | Index | Weight |
|---|---|---|
| XUHC | msci-usa-health-care | 2.18 % |
| XUHL | msci-usa-health-care | 2.18 % |
| SPFS | msci-world-health-care | 1.61 % |
| XDWH | msci-world-health-care | 1.60 % |
| XDEB | msci-world-minimum-volatility | 0.82 % |
| EXXT | nasdaq-100 | 0.62 % |
| 2B7K | msci-world-sri | 0.62 % |
| XNAS | nasdaq-100 | 0.62 % |
| XDEQ | msci-world-quality | 0.26 % |
| SXR8 | sp500 | 0.21 % |
| SPYL | sp500 | 0.21 % |
| SPY5 | sp500 | 0.21 % |
| XD9U | msci-usa | 0.21 % |
| XD9D | msci-usa | 0.21 % |
| EUNL | msci-world | 0.15 % |
| XDWD | msci-world | 0.15 % |
| SPPW | msci-world | 0.15 % |
| XDWL | msci-world | 0.15 % |
| SWWD | msci-world | 0.15 % |
| IUSQ | msci-acwi | 0.14 % |
| SPYY | msci-acwi | 0.14 % |
| WIMI | msci-world-imi | 0.14 % |
| SPYI | msci-acwi-imi | 0.13 % |
| SPSA | msci-acwi-imi | 0.13 % |
Want to know how much Vertex Pharmaceuticals Incorporated overlaps with the rest of your portfolio? Use the Portfolio X-Ray or the ETF overlap check.
Stocks with similar ETF exposure
Names that reach a portfolio through largely the same funds as Vertex Pharmaceuticals Incorporated — the figure counts the ETFs holding both.
Gilead Sciences Inc.GILD · 24 shared ETFs · r +0.49
IDEXX Laboratories Inc.IDXX · 23 shared ETFs
Amgen Inc.AMGN · 23 shared ETFs · r +0.60
Regeneron Pharmaceuticals Inc.REGN · 22 shared ETFs
DexCom Inc.DXCM · 22 shared ETFs
Quest Diagnostics IncorporatedDGX · 21 shared ETFs
Edwards Lifesciences CorporationEW · 21 shared ETFs
HCA Healthcare IncHCA · 21 shared ETFs
In the Alysly network
How Vertex Pharmaceuticals Incorporated connects to ETFs, indices and neighbouring names — every link is a measured relation, not a recommendation.
- United States Country · domicile
- XUHL ETF · holds
- XUHC ETF · holds
- XDEB ETF · holds
- XDWH ETF · holds
- SPFS ETF · holds
- Health Care Sector · sector
- Amgen Stock · similar ETF exposure
- Gilead Sciences Stock · similar ETF exposure
Latest Investment Intelligence News: Stocks
· MixedPOL tumbles 9.4% – August 26, 2026
· MixedSTX climbs 12.6% – August 25, 2026
· Risk-offSelling pressure hits markets, with only 30% of assets higher – August 24, 2026
· MixedCrypto, commodities & FX this week: Sui -9.0% · August 17–21, 2026
· MixedThe week in markets: MSCI Emerging Markets sets the tone for the week (+1.6%) · August 17–21, 2026